{"doi":"10.1084/jem.20192319","title":"Homozygous <i>STAT2</i> gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy","abstract":"Type I interferonopathies are monogenic disorders characterized by enhanced type I interferon (IFN-I) cytokine activity. Inherited USP18 and ISG15 deficiencies underlie type I interferonopathies by preventing the regulation of late responses to IFN-I. Specifically, USP18, being stabilized by ISG15, sterically hinders JAK1 from binding to the IFNAR2 subunit of the IFN-I receptor. We report an infant who died of autoinflammation due to a homozygous missense mutation (R148Q) in STAT2. The variant is a gain of function (GOF) for induction of the late, but not early, response to IFN-I. Surprisingly, the mutation does not enhance the intrinsic activity of the STAT2-containing transcriptional complex responsible for IFN-I-stimulated gene induction. Rather, the STAT2 R148Q variant is a GOF because it fails to appropriately traffic USP18 to IFNAR2, thereby preventing USP18 from negatively regulating responses to IFN-I. Homozygosity for STAT2 R148Q represents a novel molecular and clinical phenocopy of inherited USP18 deficiency, which, together with inherited ISG15 deficiency, defines a group of type I interferonopathies characterized by an impaired regulation of late cellular responses to IFN-I.","journal":"The Journal of Experimental Medicine","year":2020,"id":53086,"datarank":2.9598512804807777,"base_score":4.812184355372417,"endowment":4.812184355372417,"self_citation_contribution":0.7218276533058626,"citation_network_contribution":2.238023627174915,"self_endowment_contribution":0.7218276533058626,"citer_contribution":2.238023627174915,"corpus_percentile":null,"corpus_rank":null,"citation_count":122,"citer_count":91,"citers_with_citation_signal":78,"citers_with_endowment":78,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9518,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":270307,"name":"Marta Martín-Fernández","orcid":"0000-0003-4671-6349","position":1,"is_corresponding":false},{"id":270308,"name":"Fatima Ailal","orcid":"0000-0001-5824-3193","position":2,"is_corresponding":false},{"id":272708,"name":"Xueer Qiu","orcid":null,"position":3,"is_corresponding":false},{"id":270309,"name":"Justin Taft","orcid":"0000-0002-9998-0429","position":4,"is_corresponding":false},{"id":270310,"name":"Jennie Altman","orcid":"0000-0003-3239-1643","position":5,"is_corresponding":false},{"id":104146,"name":"Jérémie Rosain","orcid":"0000-0002-2822-161X","position":6,"is_corresponding":false},{"id":265879,"name":"Sofija Buta","orcid":"0000-0001-7662-3851","position":7,"is_corresponding":false},{"id":243781,"name":"Aziz Bousfiha","orcid":null,"position":8,"is_corresponding":false},{"id":57373,"name":"Jean-Laurent Casanova","orcid":"0000-0002-7782-4169","position":9,"is_corresponding":false},{"id":241304,"name":"Jacinta Bustamante","orcid":"0000-0002-3439-2482","position":10,"is_corresponding":false},{"id":105284,"name":"Dusan Bogunovic","orcid":"0000-0002-9277-3232","position":11,"is_corresponding":false},{"id":105215,"name":"Conor Gruber","orcid":"0000-0002-9102-8134","position":0,"is_corresponding":true}],"reference_count":31,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-18T20:44:25.349797Z","pmid":"32092142","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}